1.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation
106, 3143–3421.
2.
Harris, WS, Miller, M, Tighe, AP, et al. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis
197, 12–24.
3.
Harris, WS, Connor, WE, Alam, N, et al. (1988) Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res
29, 1451–1460.
4.
Proctor, SD, Vine, DF & Mamo, JC (2002) Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol
13, 461–470.
5.
Bravo, E, Napolitano, M & Botham, KM (2010) Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries?
Open Trans Med J
2, 1–13.
6.
Roche, HM & Gibney, MJ (2000) The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk
7, 317–324.
7.
Nordestgaard, BG, Benn, M, Schnohr, P, et al. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA
298, 299–308.
8.
Bansal, S, Buring, JE, Rifai, N, et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA
298, 309–316.
9.
Hyson, D, Rutledge, JC & Berglund, L (2003) Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep
5, 437–444.
10.
Schuchardt, JP & Hahn, A (2013) Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids
89, 1–8.
11.
Dyerberg, J, Madsen, P, Moller, JM, et al. (2010) Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids
83, 137–141.
12.
Neubronner, J, Schuchardt, JP, Kressel, G, et al. (2011) Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur J Clin Nutr
65, 247–254.
13.
Esterbauer, H, Schaur, RJ & Zollner, H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med
11, 81–128.
14.
European Food Safety Authority (EFSA) (2011) Scientific opinion on fish oil for human consumption. Food hygiene, including rancidity. EFSA J
8, 1874.
15.
Council of Europe (2011) European Pharmacopoeia, 7th ed. Supplement 6.3. Strasbourg, France:
Council of Europe.
16.
Albert, BB, Derraik, JG, Cameron-Smith, D, et al. (2015) Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep
5, 7928.
17.
Blomhoff, R (2005) Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol
16, 47–54.
18.
Fierens, C & Corthout, J (2007) Omega-3 fatty acid preparations – a comparative study. J Pharm Belg
62, 115–119.
19.
Jackowski, SA, Alvi, AZ, Mirajkar, A, et al. (2015) Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety. J Nutr Sci
4, e30.
20.
Luley, C, Klein, B, Hanisch, M, et al. (1988) Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations. Arzneimittelforschung
38, 1783–1786.
21.
Opperman, M & Benade, S (2013) Analysis of the omega-3 fatty acid content of South African fish oil supplements: a follow-up study. Cardiovasc J Afr
24, 297–302.
22.
Ottestad, I, Vogt, G, Retterstol, K, et al. (2011) Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial. Br J Nutr
108, 315–326.
23.
Garcia-Hernandez, VM, Gallar, M, Sanchez-Soriano, J, et al. (2013) Effect of omega-3 dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial. Int J Food Sci Nutr
64, 993–1000.
24.
Sutherland, WH, de Jong, SA, Walker, RJ, et al. (2002) Effect of meals rich in heated olive and safflower oils on oxidation of postprandial serum in healthy men. Atherosclerosis
160, 195–203.
25.
Staprans, I, Rapp, JH, Pan, XM, et al. (1994) Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler Thromb
14, 1900–1905.
26.
Naruszewicz, M, Wozny, E, Mirkiewicz, E, et al. (1987) The effect of thermally oxidized soya bean oil on metabolism of chylomicrons. Increased uptake and degradation of oxidized chylomicrons in cultured mouse macrophages. Atherosclerosis
66, 45–53.
27.
Negre-Salvayre, A, Auge, N, Ayala, V, et al. (2010) Pathological aspects of lipid peroxidation. Free Radic Res
44, 1125–1171.
28.
Niki, E, Yoshida, Y, Saito, Y, et al. (2005) Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun
338, 668–676.
29.
Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol
37, 911–917.
30.
Ghasemifard, S, Turchini, GM & Sinclair, AJ (2014) Omega-3 long chain fatty acid ‘bioavailability’: a review of evidence and methodological considerations. Prog Lipid Res
56, 92–108.
31.
Schram, LB, Nielsen, CJ, Porsgaard, T, et al. (2007) Food matrices affect the bioavailability of (n-3) polyunsaturated fatty acids in a single meal study in humans. Food Res Int
40, 1062–1068.
32.
Raatz, SK, Redmon, JB, Wimmergren, N, et al. (2009) Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil. J Am Diet Assoc
109, 1076–1081.
33.
Garaiova, I, Guschina, IA, Plummer, SF, et al. (2007) A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J
6, 4.
34.
Raatz, SK, Bibus, D, Thomas, W, et al. (2001) Total fat intake modifies plasma fatty acid composition in humans. J Nutr
131, 231–234.
35.
Harris, WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res
30, 785–807.
36.
Armand, M, Pasquier, B, Andre, M, et al. (1999) Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am J Clin Nutr
70, 1096–1106.
37.
Harris, WS & Muzio, F (1993) Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr
58, 68–74.
38.
Hedengran, A, Szecsi, PB, Dyerberg, J, et al. (2015)
n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial. Lipids
50, 165–175.
39.
Miyoshi, T, Noda, Y, Ohno, Y, et al. (2014) Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals – a randomized cross-over trial. Biomed Pharmacother
68, 1071–1077.
40.
Song, Z, Yang, L, Shu, G, et al. (2013) Effects of the n-6/n-3 polyunsaturated fatty acids ratio on postprandial metabolism in hypertriacylglycerolemia patients. Lipids Health Dis
12, 181.